More on Hospira (HSP +6.2%) Q2: swings to net loss of $2.5M from a profit of $143.6M a year...


More on Hospira (HSP +6.2%) Q2: swings to net loss of $2.5M from a profit of $143.6M a year earlier, due to charges related to quality control and restructuring, lower sales, and higher costs. Expects FY EPS at lower end of estimate of $2-$2.30 vs. consensus of $2.11.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs